Systematic review on the incidence of bisphosphonate related osteonecrosis of the jaw in children diagnosed with osteogenesis imperfecta

Anusha Adeline Hennedige, Jap Jayasinghe, Janette Khajeh, Tatiana MacFarlane

Research output: Contribution to journalArticle

Abstract

OBJECTIVES: To conduct a systematic review of epidemiological literature to determine the incidence of bisphosphonate related osteonecrosis of the jaw occurring either spontaneously or after dental surgery, in children and adolescents diagnosed with osteogenesis imperfecta.

MATERIAL AND METHODS: MEDLINE, HMIC and EMBASE were used to search for English-language articles published from 1946 - 2013. Inclusion criteria consisted of population based studies of children and adolescents (24 years and younger) diagnosed with osteogenesis imperfecta, only studies which included a dental examination, and patients treated with intravenous bisphosphonates were included. Articles were excluded if patients had any other co-morbidity which could affect osteonecrosis of the jaw, and those which treated patients with oral bisphosphonates only.

RESULTS: Five studies consisting of four retrospective cohort studies and one case series were identified. Study populations ranged from 15 to 278 patients and number of subjects with osteogenesis imperfecta ranged from 15 to 221. Mean duration of intravenous bisphosphonate use ranged from 4.5 to 6.8 years. All patients were clinically examined and no patients were found to have osteonecrosis of the jaw.

CONCLUSIONS: There is no evidence to support hypothesis of causal relationship between bisphosphonates and osteonecrosis of the jaw in children and adolescents with osteogenesis imperfecta. More prospective studies on bisphosphonate use in osteogenesis imperfecta needs to be carried out.

Original languageEnglish
Pages (from-to)e1
JournalJournal of Oral & Maxillofacial Research
Volume4
Issue number4
DOIs
Publication statusPublished - Oct 2013

Fingerprint

Bisphosphonate-Associated Osteonecrosis of the Jaw
Osteogenesis Imperfecta
Diphosphonates
Incidence
Jaw
Osteonecrosis
Tooth
MEDLINE
Population
Cohort Studies
Language
Retrospective Studies
Prospective Studies
Morbidity

Keywords

  • osteonecrosis
  • jaw
  • osteogenesis imperfecta
  • children
  • bisphosphonates

Cite this

Systematic review on the incidence of bisphosphonate related osteonecrosis of the jaw in children diagnosed with osteogenesis imperfecta. / Hennedige, Anusha Adeline; Jayasinghe, Jap; Khajeh, Janette; MacFarlane, Tatiana.

In: Journal of Oral & Maxillofacial Research, Vol. 4, No. 4, 10.2013, p. e1.

Research output: Contribution to journalArticle

@article{9c55d58a92c043398cc1a718b44d3895,
title = "Systematic review on the incidence of bisphosphonate related osteonecrosis of the jaw in children diagnosed with osteogenesis imperfecta",
abstract = "OBJECTIVES: To conduct a systematic review of epidemiological literature to determine the incidence of bisphosphonate related osteonecrosis of the jaw occurring either spontaneously or after dental surgery, in children and adolescents diagnosed with osteogenesis imperfecta.MATERIAL AND METHODS: MEDLINE, HMIC and EMBASE were used to search for English-language articles published from 1946 - 2013. Inclusion criteria consisted of population based studies of children and adolescents (24 years and younger) diagnosed with osteogenesis imperfecta, only studies which included a dental examination, and patients treated with intravenous bisphosphonates were included. Articles were excluded if patients had any other co-morbidity which could affect osteonecrosis of the jaw, and those which treated patients with oral bisphosphonates only.RESULTS: Five studies consisting of four retrospective cohort studies and one case series were identified. Study populations ranged from 15 to 278 patients and number of subjects with osteogenesis imperfecta ranged from 15 to 221. Mean duration of intravenous bisphosphonate use ranged from 4.5 to 6.8 years. All patients were clinically examined and no patients were found to have osteonecrosis of the jaw.CONCLUSIONS: There is no evidence to support hypothesis of causal relationship between bisphosphonates and osteonecrosis of the jaw in children and adolescents with osteogenesis imperfecta. More prospective studies on bisphosphonate use in osteogenesis imperfecta needs to be carried out.",
keywords = "osteonecrosis, jaw, osteogenesis imperfecta, children, bisphosphonates",
author = "Hennedige, {Anusha Adeline} and Jap Jayasinghe and Janette Khajeh and Tatiana MacFarlane",
year = "2013",
month = "10",
doi = "10.5037/jomr.2013.4401",
language = "English",
volume = "4",
pages = "e1",
journal = "Journal of Oral & Maxillofacial Research",
issn = "2029-283X",
number = "4",

}

TY - JOUR

T1 - Systematic review on the incidence of bisphosphonate related osteonecrosis of the jaw in children diagnosed with osteogenesis imperfecta

AU - Hennedige, Anusha Adeline

AU - Jayasinghe, Jap

AU - Khajeh, Janette

AU - MacFarlane, Tatiana

PY - 2013/10

Y1 - 2013/10

N2 - OBJECTIVES: To conduct a systematic review of epidemiological literature to determine the incidence of bisphosphonate related osteonecrosis of the jaw occurring either spontaneously or after dental surgery, in children and adolescents diagnosed with osteogenesis imperfecta.MATERIAL AND METHODS: MEDLINE, HMIC and EMBASE were used to search for English-language articles published from 1946 - 2013. Inclusion criteria consisted of population based studies of children and adolescents (24 years and younger) diagnosed with osteogenesis imperfecta, only studies which included a dental examination, and patients treated with intravenous bisphosphonates were included. Articles were excluded if patients had any other co-morbidity which could affect osteonecrosis of the jaw, and those which treated patients with oral bisphosphonates only.RESULTS: Five studies consisting of four retrospective cohort studies and one case series were identified. Study populations ranged from 15 to 278 patients and number of subjects with osteogenesis imperfecta ranged from 15 to 221. Mean duration of intravenous bisphosphonate use ranged from 4.5 to 6.8 years. All patients were clinically examined and no patients were found to have osteonecrosis of the jaw.CONCLUSIONS: There is no evidence to support hypothesis of causal relationship between bisphosphonates and osteonecrosis of the jaw in children and adolescents with osteogenesis imperfecta. More prospective studies on bisphosphonate use in osteogenesis imperfecta needs to be carried out.

AB - OBJECTIVES: To conduct a systematic review of epidemiological literature to determine the incidence of bisphosphonate related osteonecrosis of the jaw occurring either spontaneously or after dental surgery, in children and adolescents diagnosed with osteogenesis imperfecta.MATERIAL AND METHODS: MEDLINE, HMIC and EMBASE were used to search for English-language articles published from 1946 - 2013. Inclusion criteria consisted of population based studies of children and adolescents (24 years and younger) diagnosed with osteogenesis imperfecta, only studies which included a dental examination, and patients treated with intravenous bisphosphonates were included. Articles were excluded if patients had any other co-morbidity which could affect osteonecrosis of the jaw, and those which treated patients with oral bisphosphonates only.RESULTS: Five studies consisting of four retrospective cohort studies and one case series were identified. Study populations ranged from 15 to 278 patients and number of subjects with osteogenesis imperfecta ranged from 15 to 221. Mean duration of intravenous bisphosphonate use ranged from 4.5 to 6.8 years. All patients were clinically examined and no patients were found to have osteonecrosis of the jaw.CONCLUSIONS: There is no evidence to support hypothesis of causal relationship between bisphosphonates and osteonecrosis of the jaw in children and adolescents with osteogenesis imperfecta. More prospective studies on bisphosphonate use in osteogenesis imperfecta needs to be carried out.

KW - osteonecrosis

KW - jaw

KW - osteogenesis imperfecta

KW - children

KW - bisphosphonates

U2 - 10.5037/jomr.2013.4401

DO - 10.5037/jomr.2013.4401

M3 - Article

VL - 4

SP - e1

JO - Journal of Oral & Maxillofacial Research

JF - Journal of Oral & Maxillofacial Research

SN - 2029-283X

IS - 4

ER -